XML 44 R32.htm IDEA: XBRL DOCUMENT
v3.10.0.1

Revenue from contracts with customers (Tables) | 9 Months Ended
--- | ---
Sep. 30, 2018
Summary of disaggregates revenues by major revenue streams | The following table disaggregates Teva’s revenues by major revenue streams. For additional information on disaggregation of revenues see note 17.
|  | Three months ended September 30, 2018 |
|  | North America |  |  | Europe |  |  | International Markets |  |  | Other activities |  |  | Total |
|  | (U.S. $ in millions) |
Sale of goods |  |  | 1,902 |  |  |  | 1,210 |  |  |  | 525 |  |  |  | 166 |  |  |  | 3,803 |
Licensing arrangements |  |  | 29 |  |  |  | 1 |  |  |  | — |  |  |  | 2 |  |  |  | 32 |
Distribution |  |  | 333 |  |  |  | 1 |  |  |  | 149 |  |  |  | — |  |  |  | 483 |
Other |  |  | 1 |  |  |  | — |  |  |  | 52 |  |  |  | 158 |  |  |  | 211 |
|  | $ | 2,265 |  |  | $ | 1,212 |  |  | $ | 726 |  |  | $ | 326 |  |  | $ | 4,529 |
|  | Three months ended September 30, 2017 |
|  | North America |  |  | Europe |  |  | International Markets |  |  | Other activities |  |  | Total |
|  | (U.S. $ in millions) |
Sale of goods |  |  | 2,724 |  |  |  | 1,321 |  |  |  | 672 |  |  |  | 168 |  |  |  | 4,885 |
Licensing arrangements |  |  | 25 |  |  |  | — |  |  |  | 1 |  |  |  | 1 |  |  |  | 27 |
Distribution |  |  | 294 |  |  |  | 59 |  |  |  | 146 |  |  |  | — |  |  |  | 499 |
Other |  |  | — |  |  |  | — |  |  |  | 63 |  |  |  | 143 |  |  |  | 206 |
|  | $ | 3,043 |  |  | $ | 1,380 |  |  | $ | 882 |  |  | $ | 312 |  |  | $ | 5,617 |
|  | Nine months ended September 30, 2018 |
|  | North America |  |  | Europe |  |  | International Markets |  |  | Other activities |  |  | Total |
|  | (U.S. $ in millions) |
Sale of goods |  |  | 5,983 |  |  |  | 3,956 |  |  |  | 1,617 |  |  |  | 526 |  |  |  | 12,082 |
Licensing arrangements |  |  | 91 |  |  |  | 19 |  |  |  | 21 |  |  |  | 6 |  |  |  | 137 |
Distribution |  |  | 984 |  |  |  | 7 |  |  |  | 456 |  |  |  | — |  |  |  | 1,447 |
Other |  |  | 1 |  |  |  | — |  |  |  | 171 |  |  |  | 457 |  |  |  | 629 |
|  | $ | 7,059 |  |  | $ | 3,982 |  |  | $ | 2,265 |  |  | $ | 989 |  |  | $ | 14,295 |
|  | Nine months ended September 30, 2017 |
|  | North America |  |  | Europe |  |  | International Markets |  |  | Other activities |  |  | Total |
|  | (U.S. $ in millions) |
Sale of goods |  |  | 8,338 |  |  |  | 3,848 |  |  |  | 1,862 |  |  |  | 567 |  |  |  | 14,615 |
Licensing arrangements |  |  | 249 |  |  |  | 2 |  |  |  | 36 |  |  |  | 4 |  |  |  | 291 |
Distribution |  |  | 864 |  |  |  | 166 |  |  |  | 406 |  |  |  | — |  |  |  | 1,436 |
Other |  |  | 1 |  |  |  | — |  |  |  | 181 |  |  |  | 463 |  |  |  | 645 |
|  | $ | 9,452 |  |  | $ | 4,016 |  |  | $ | 2,485 |  |  | $ | 1,034 |  |  | $ | 16,987 |
Summary of Sales Reserves and Allowances | SR&A to U.S. customers comprised approximately 84% of the Company’s total SR&A as of September 30, 2018, with the remaining balance primarily in Canada and Germany. The changes in SR&A for third-party sales for the period ended September 30, 2018 were as follows:
|  | Sales Reserves and Allowances |  |  |  |
|  | Reserves included in Accounts Receivable, net |  |  | Rebates |  |  | Medicaid and other governmental allowances |  |  | Chargebacks |  |  | Returns |  |  | Other |  |  | Total reserves included in Sales Reserves and Allowances |  |  | Total |
|  | (U.S.$ in millions) |
Balance at December 31, 2017 |  | $ | 196 |  |  | $ | 3,077 |  |  | $ | 1,908 |  |  | $ | 1,849 |  |  | $ | 780 |  |  | $ | 267 |  |  | $ | 7,881 |  |  | $ | 8,077 |
Provisions related to sales made in current year period |  |  | 380 |  |  |  | 4,956 |  |  |  | 931 |  |  |  | 7,738 |  |  |  | 232 |  |  |  | 309 |  |  |  | 14,166 |  |  |  | 14,546 |
Provisions related to sales made in prior periods |  |  | 7 |  |  |  | (39 | ) |  |  | 17 |  |  |  | 3 |  |  |  | 21 |  |  |  | (19 | ) |  |  | (17 | ) |  |  | (10 | )
Credits and payments |  |  | (412 | ) |  |  | (5,082 | ) |  |  | (1,288 | ) |  |  | (8,203 | ) |  |  | (364 | ) |  |  | (354 | ) |  |  | (15,291 | ) |  |  | (15,703 | )
Translation differences |  |  | — |  |  |  | (20 | ) |  |  | (4 | ) |  |  | (3 | ) |  |  | (4 | ) |  |  | (7 | ) |  |  | (38 | ) |  |  | (38 | )
Balance at September 30, 2018 |  | $ | 171 |  |  |  | 2,892 |  |  | $ | 1,564 |  |  | $ | 1,384 |  |  | $ | 665 |  |  | $ | 196 |  |  | $ | 6,701 |  |  | $ | 6,872 |

X
- Definition Tabular disclosure of sales reserves and allowances current. + References No definition available. + Details
Name: | teva_SalesReservesAndAllowancesCurrentTableTextBlock
Namespace Prefix: | teva_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 606 -SubTopic 10 -Section 50 -Paragraph 5 -URI http://asc.fasb.org/extlink&oid=109196051&loc=SL49130545-203045 + Details
Name: | us-gaap_DisaggregationOfRevenueTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration